Related Experiment Videos
NMDA antagonists potentiate scopolamine-induced amnesic effect
1Division of Pharmacology, Research Institute for Wakan-Yaku (Oriental Medicines), Toyama Medical and Pharmaceutical University, Japan.
Behavioural Brain Research
|February 1, 1997
Summary
N-methyl-D-aspartate (NMDA) receptor antagonists worsen memory deficits caused by scopolamine in rats. These NMDA antagonists negatively impact short-term memory and cognitive function.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Scopolamine, a muscarinic antagonist, impairs cognitive function.
- N-methyl-D-aspartate (NMDA) receptors are crucial for learning and memory.
Purpose of the Study:
- To investigate the effects of NMDA receptor antagonists on scopolamine-induced amnesia.
- To assess the impact of NMDA antagonists on short-term memory performance.
Main Methods:
- Utilized an 8-arm radial maze task in rats.
- Administered scopolamine, MK-801 (NMDA receptor channel blocker), and CGS-19755 (competitive NMDA receptor antagonist).
- Evaluated performance in non-delayed and delay-interposed (5-min) tasks.
Main Results:
- Scopolamine impaired radial maze performance.
- MK-801 and CGS-19755 did not hinder spatial cognition in the non-delayed task.
- Both NMDA antagonists exacerbated scopolamine-induced deficits and impaired short-term memory in the delayed task.
Conclusions:
- NMDA receptor antagonists negatively affect short-term memory.
- The interaction between the NMDA and central muscarinic systems modulates cognitive function.